Shopping Cart
- Remove All
Your shopping cart is currently empty
xStAx-VHLL TFA is a β-catenin degrader formed by coupling xStAx to VHL ligand, has anti-cancer activity, inhibits Wnt signaling, and can be used in the study of cancer.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $94 | In Stock | |
| 5 mg | $242 | In Stock | |
| 10 mg | $389 | In Stock | |
| 25 mg | $642 | In Stock | |
| 50 mg | $883 | In Stock | |
| 100 mg | $1,190 | In Stock |
| Description | xStAx-VHLL TFA is a β-catenin degrader formed by coupling xStAx to VHL ligand, has anti-cancer activity, inhibits Wnt signaling, and can be used in the study of cancer. |
| In vitro | Both 10 μM MSAB and 50 μM xStAx-VHLL TFA decreased β-catenin protein to a comparable level after 24 h treatment in HEK293T, HCT116, and SW480 cells. In LoVo cells, only xStAx-VHLL TFA was able to reduce the β-catenin protein level, while MSAB had no effect. [1] |
| In vivo | Because APCmin/+ mice can develop intestinal tumors around 10 weeks-old, the 11 weeks-old APCmin/+ mice were intraperitoneally injected with 30 mg/kg vehicle DMSO or xStAx-VHLL TFA at every other day for 14 days. The xStAx-VHLL TFA reduced tumor number compared with that of 11 weeks-old mice before treatment (day 0) or with vehicle DMSO treatment. [1] |
| Molecular Weight | 3231.89 (free base) |
| Formula | C154H244N48O29.xC2HF3O2 |
| Color | White |
| Appearance | Solid |
| Sequence | Ac-Arg-Arg-Trp-Pro-Arg-{S5}-Ile-Leu-Asp-{S5}-His-Val-Arg-Arg-Val-Trp-Arg-{Ahx}-Ala-Leu-Ala-Pro-Tyr-Ile-Pro-NH2 |
| Sequence Short | Ac-RRWPR{S5}ILD{S5}HVRRVWR-{Ahx}-ALAPYIP-NH2 |
| Storage | keep away from moisture,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO: 80 mg/mL, Sonication is recommended. H2O: 80 mg/mL, Sonication is recommended. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.